5 years ago

biotechdispatch.com.au

Noxopharm announces Veyonda to be studied in new immunotherapy trial

5 years ago

biotechdispatch.com.au

AVITA Therapeutics inks new deal for skin restoration platform

5 years ago

fool.com.au

Why the Redbubble (ASX:RBL) share price has crashed 20% lower today

5 years ago

afr.com

Galilee Energy taps Canaccord for placement to fund exploration

5 years ago

afr.com

PAC, Bells blast terms for Buderim Group

5 years ago

miningnews.net

Apollo Hill gold hits continue for Saturn

5 years ago

fool.com.au

The OFX (ASX:OFX) share price slumps with ASX tech stocks after posting its results

5 years ago

raskmedia.com.au

I’d buy A2 Milk (ASX:A2M) and two other ASX shares in this vaccine rally

5 years ago

fool.com.au

Why the LiveTiles (ASX:LVT) share price is jumping 6% higher today

5 years ago

proactiveinvestors.com.au

Alicanto Minerals hits chalcopyrite copper at second target within Greater Falun project in Sweden